SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Drugs for the Treatment of No-Reflow During PCI

Dr. Omar Tupayachi - 20 March, 2026 0

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

Dr. Juan Manuel Pérez - 18 March, 2026 0

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Dr. Omar Tupayachi - 17 March, 2026 0

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: Drugs

Drugs for the Treatment of No-Reflow During PCI

Últimas Noticias

Drugs for the Treatment of No-Reflow During PCI

Coronary revascularization before TAVI: prior PCI or conservative management?

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Noticias Institucionales

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

Accesos